Succinic semialdehyde dehydrogenase (SSADH) deficiency: Molecular analysis in a South American family
β Scribed by Aida Lemes; Paola Blasi; Gabriel Gonzales; Maria E. Russi; Roberto Quadrelli; Andrea Novelletto; Patrizia Malaspina
- Book ID
- 106374071
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 140 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0141-8955
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background SSADH (aldehyde dehydrogenase 5a1 (Aldh5a1); Ξ³-hydroxybutyric (GHB) aciduria) deficiency is a defect of GABA degradation in which the neuromodulators GABA and GHB accumulate. The human phenotype is that of nonprogressive encephalopathy with prominent bilateral discolorati
Succinate semialdehyde dehydrogenase (SSADH; ALDH5A1) deficiency, a rare metabolic disorder that disrupts the normal degradation of GABA, gives rise to a highly heterogeneous neurological phenotype ranging from mild to very severe. The nature of the mutation has so far been reported in patients from